Zhou J - Search Results

1

A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8.

Zhou L, Le MNU, Du Y, Chen X, Jin M, Xiang H, Xia LE, Zhou J, He J, Ning Y. Zhou L, et al. Among authors: zhou j. Gene. 2024 Jul 20;916:148449. doi: 10.1016/j.gene.2024.148449. Epub 2024 Apr 6. Gene. 2024. PMID: 38588931

2

CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.

Ning Y, Wang C, Liu X, Du Y, Liu S, Liu K, Zhou J, Zhou C. Ning Y, et al. Among authors: zhou j, zhou c. J Exp Clin Cancer Res. 2019 Mar 18;38(1):131. doi: 10.1186/s13046-019-1137-8. J Exp Clin Cancer Res. 2019. PMID: 30885251 Free PMC article.

3

ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.

Ning Y, Hui N, Qing B, Zhuo Y, Sun W, Du Y, Liu S, Liu K, Zhou J. Ning Y, et al. Among authors: zhou j. Cell Death Dis. 2019 May 28;10(6):414. doi: 10.1038/s41419-019-1635-9. Cell Death Dis. 2019. PMID: 31138778 Free PMC article.

4

ChIP-chip data for identifying target genes and consensus binding sequences of mutant p53 in MDA-MB-468 breast cancer cells.

Le MNU, Ning Y, Zhou J. Le MNU, et al. Among authors: zhou j. Data Brief. 2023 Aug 18;50:109499. doi: 10.1016/j.dib.2023.109499. eCollection 2023 Oct. Data Brief. 2023. PMID: 37663770 Free PMC article.

5

Datasets for the effects of RUNX2 silencing on transcriptomic and metabolomic profiles in SJSA-1 osteosarcoma cells.

Le MNU, Chen R, Xia LE, Zhou J, Ning Y. Le MNU, et al. Among authors: zhou j. Data Brief. 2023 Aug 18;50:109500. doi: 10.1016/j.dib.2023.109500. eCollection 2023 Oct. Data Brief. 2023. PMID: 37663774 Free PMC article.

6

MAEL contributes to gastric cancer progression by promoting ILKAP degradation.

Zhang X, Ning Y, Xiao Y, Duan H, Qu G, Liu X, Du Y, Jiang D, Zhou J. Zhang X, et al. Among authors: zhou j. Oncotarget. 2017 Dec 6;8(69):113331-113344. doi: 10.18632/oncotarget.22970. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371914 Free PMC article.

7

The miR-193a-5p/NCX2/AKT axis promotes invasion and metastasis of osteosarcoma.

Chen R, Ning Y, Zeng G, Zhou H, Zhou L, Xiao P, Li Z, Zhou J. Chen R, et al. Among authors: zhou h, zhou j, zhou l. J Cancer. 2021 Aug 8;12(19):5903-5913. doi: 10.7150/jca.60969. eCollection 2021. J Cancer. 2021. PMID: 34476004 Free PMC article.

8

Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.

Zhou H, Zhang Q, Huang W, He C, Zhou C, Zhou J, Ning Y. Zhou H, et al. Among authors: zhou j, zhou c. Int J Oncol. 2023 May;62(5):64. doi: 10.3892/ijo.2023.5512. Epub 2023 Apr 13. Int J Oncol. 2023. PMID: 37052262 Free PMC article.

9

MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers.

Zhou J, Duan H, Xie Y, Ning Y, Zhang X, Hui N, Wang C, Zhang J, Zhou J. Zhou J, et al. J Cancer. 2016 Aug 7;7(12):1740-1746. doi: 10.7150/jca.15620. eCollection 2016. J Cancer. 2016. PMID: 27698912 Free PMC article.

10

The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.

Zhou L, Zhang Q, Deng H, Ou S, Liang T, Zhou J. Zhou L, et al. Among authors: zhou j. Tohoku J Exp Med. 2022 Nov 11;258(4):265-276. doi: 10.1620/tjem.2022.J083. Epub 2022 Oct 14. Tohoku J Exp Med. 2022. PMID: 36244757 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,233 results

Search Page

Filters